Pharmicell Co (XKRX:005690) Cash Flow for Lease Financing : ₩-392 Mil (TTM As of Mar. 2024)

View and export this data going back to 1988. Start your Free Trial

What is Pharmicell Co Cash Flow for Lease Financing?

Pharmicell Co's Cash Flow for Lease Financing for the three months ended in Mar. 2024 was ₩-87 Mil. Pharmicell Co's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-392 Mil.

Compared with last quarter (₩-165 Mil in Dec. 2023 ), Pharmicell Co's Cash Flow for Lease Financing increased in Mar. 2024 (₩-87 Mil).

Pharmicell Co Cash Flow for Lease Financing Historical Data

The historical data trend for Pharmicell Co's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmicell Co Cash Flow for Lease Financing Chart

Pharmicell Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash Flow for Lease Financing

Get a 7-Day Free Trial

-145.05

-178.48

-373.41

-269.81

-317.67

Pharmicell Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash Flow for Lease Financing	Get a 7-Day Free Trial															-13.12	-139.28	-	-165.28	-87.20

Pharmicell Co Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.

Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-392 Mil.

Pharmicell Co Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Pharmicell Co's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmicell Co (XKRX:005690) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmicell Co Ltd (XKRX:005690) » Definitions » Cash Flow for Lease Financing

Comparable Companies

Traded in Other Exchanges

N/A

Address

12F Chungho B/D, 3-2 Nonhyun-dong Gangnam-gu, Seoul, KOR, 135-010

Website

http://www.pharmicell.com

Pharmicell Co Ltd is a biotechnology company, engages in the manufacturing of biopharmaceutical medicines in South Korea. Its biopharmaceutical business engages in the development and manufacture of stem cell therapeutic drugs and stem cell-based cosmetics and others. Its products under development include mesenchymal stem cell products, such as Cellgram_AMI, a heart disease drug; Cellgram_IS and Cellgram_SCI, which are brain/nerve disorder drugs; Cellgram_Lung, a pulmonary disease drug; Cellgram_LC, a liver disease drug; and Cellgram_ED and Cellgram_CLI for the treatment of graft-versus-host disease, kidney transplant, impotence, and critical lower limb ischemia.

Pharmicell Co (XKRX:005690) Headlines

No Headlines